Immuno-Oncology and Technology Oncology
Germline BRCA1 pathogenic variants and T cell dysfunction
The publisher did not provide an abstract — full text is available via the link below.
Immuno-Oncology and Technology Oncology
The publisher did not provide an abstract — full text is available via the link below.